AMICUS THERAPEUTICS INC. - COMMON STOCK

Amicus Therapeutics Receives Positive CHMP Opinion for Pombiliti™ (cipaglucosidase alfa) for Late-Onset Pompe Disease

16 12 2022 08:10:56 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the Stifel 2022 Healthcare Conference

15 11 2022 07:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Provides EU Regulatory Update for AT-GAA

07 11 2022 12:20:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces Third Quarter 2022 Financial Results and Corporate Updates

07 11 2022 07:00:01 提供 Nasdaq GlobeNewswire

U.S. FDA Defers Action on Filing for AT-GAA in Late-onset Pompe Disease

28 10 2022 16:01:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Announce Third Quarter 2022 Financial Results on November 7, 2022

27 10 2022 07:00:01 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces Participation at World Muscle Society 2022

11 10 2022 07:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces Participation at the 2022 AANEM Annual Meeting

21 9 2022 07:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

08 9 2022 07:00:01 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces Second Quarter 2022 Financial Results

04 8 2022 07:00:03 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Announce Second Quarter 2022 Financial Results on August 4, 2022

26 7 2022 07:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference

08 6 2022 07:00:01 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Receives Notification of PDUFA Date Extensions for AT-GAA

10 5 2022 16:01:00 提供 Nasdaq GlobeNewswire

CORRECTING AND REPLACING -- Amicus Therapeutics Announces First Quarter 2022 Financial Results

09 5 2022 09:15:35 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces First Quarter 2022 Financial Results

09 5 2022 07:00:01 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the Bank of America 2022 Healthcare Conference

04 5 2022 07:00:02 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Announce First Quarter 2022 Financial Results on May 9, 2022

26 4 2022 07:00:00 提供 Nasdaq GlobeNewswire

Amicus Announces Issuance of New U.S. Composition of Matter Patent for Galafold® (migalastat), Strengthening Patent Protection Through 2038

19 4 2022 07:00:01 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces Positive Long-Term Data from Phase 1/2 Study of AT-GAA in Pompe Disease at the 2022 MDA Clinical & Scientific Conference

16 3 2022 07:00:01 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces Presentation and Posters at the 2022 MDA Clinical & Scientific Conference

10 3 2022 07:00:01 提供 Nasdaq GlobeNewswire